References
- Gosavi S, Channa R, Mukherjee D. Systemic hypertension in patients with aortic stenosis: clinicImplications and principles of pharmacological therapy. Cardiovasc Hematol Agents Med Chem. 2015;13(1):50–53. doi:https://doi.org/10.2174/187152571301150730114814.
- OW N, Saiadieh A, Sabbah M, AM G, MH O, Boman K, Nienaber CA, Kesäniemi YA, Pedersen TR, Willenheimer R, et al. Assessing optimal blood pressure in patients with asymptomatic aortic valve stenosis: theSimvastatin ezetimibe in aortic stenosis study(SEAS). Circulation. 2016;134(6):455–68. doi:https://doi.org/10.1161/CIRCULATIONAHA.115.021213.
- Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP3, RA G, PT O, CE R, NJ S, Sorajja P, ACC/AHA Task Force Members., et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: areport of the american college of cardiology/american heart association task force on practice guidelines. Circulation. 2014;129(23):e521–643. doi:https://doi.org/10.1161/CIR.0000000000000031.
- Shah SP, Kumar A, Draper TS, Gaasch WH. Hypertension in patients with severe aortic stenosis: emphasison antihypertensive treatment and the risk of syncope. Curr Hypertens Rev. 2014;10(3):149–54. doi:https://doi.org/10.2174/1573402111666150108101438.
- Nadir MA, Wei L, Elder DH, Libianto R, Lim TK, Pauriah M, Pringle SD, Doney AD, Choy AM, Struthers AD, et al. Impact of renin-angiotensin system blockade therapy on outcome in aortic stenosis. J Am Coll Cardiol. 2011;58(6):570–76. doi:https://doi.org/10.1016/j.jacc.2011.01.063.
- Briand M, Dumesnil JG, Kadem L, Tongue AG, Rieu R, Garcia D, Pibarot P. Reduced systemic arterial compliance impacts significantly on left ventricular afterload and function in aortic stenosis: implications for diagnosis and treatment. J Am Coll Cardiol. 2005;46(2):291–98. doi:https://doi.org/10.1016/j.jacc.2004.10.081.
- Sutton R, Ammirati F, Blanc JJ, Brignole M, Dahm JB, Deharo JC, Gajek J, Gjesdal K, Krahn A, Massin M, et al. The Task Force for the Diagnosis and Management of Syncope; European Society of Cardiology (ESC); European Heart Rhythm Association (EHRA); Heart Failure Association (HFA); Heart Rhythm Society (HRS)Moya A. Guidelines for the diagnosis and management of syncope (version 2009). Eur Heart J. 2009;30:2631–71.
- Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, et al. Recommendations for chamber quantification: a report from the american society of echocardiography’s guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the european association of echocardiography, a branch of the european society of cardiology. J Am Soc Echocardiogr. 2005;18:1440–63. doi:https://doi.org/10.1016/j.echo.2005.10.005. Chamber Quantification Writing Group; American Society of Echocardiography’s Guidelines and Standards Committee; European Association of Echocardiography.
- Hachicha Z, Dumesnil JG, Bogaty P, Pibarot P. Paradoxical low-flow, low-gradient severe aortic stenosis despite preserved ejection fraction is associated with higher afterload and reduced survival. Circulation. 2007;115(22):2856–64. doi:https://doi.org/10.1161/CIRCULATIONAHA.106.668681.
- de Simone G, Roman MJ, Koren MJ, Mensah GA, Ganau A, Devereux RB. Stroke volume/pulse pressure ratio and cardiovascular risk in arterial hypertension. Hypertension. 1999;33(3):800–05. doi:https://doi.org/10.1161/01.HYP.33.3.800.
- Baumgartner H, Hung J, Bermajo J, Chambers JB, Evangelista A, Griffin BP, Iung B, Otto CM, Pellikka PA, Quiñones M. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr. 2009;22(1):1–23. doi:https://doi.org/10.1016/j.echo.2008.11.029.
- Gaasch WH, Zile MR. Left ventricular structural remodeling in health and disease: with special emphasis on volume, mass, andgeometry. J Am Coll Cardiol. 2011;58(17):1733–40. doi:https://doi.org/10.1016/j.jacc.2011.07.022.
- Carabello BA, Paulus WJ. Aortic stenosis. Lancet. 2009;373(9667):956–66. doi:https://doi.org/10.1016/S0140-6736(09)60211-7.
- Otto CM. Valvular aortic stenosis: disease severity and timing of intervention. J Am Coll Cardiol. 2006;47(11):2141–51. doi:https://doi.org/10.1016/j.jacc.2006.03.002.
- Lindman BR, Bonow RO, Otto CM. Current management of calcific aortic stenosis. Circ Res. 2013;113(2):223–37. doi:https://doi.org/10.1161/CIRCRESAHA.111.300084.
- Cohn JN, Franciosa JA. Vasodilator therapy of cardiac failure (second of two parts). N Engl J Med. 1977;297(5):254–58. doi:https://doi.org/10.1056/NEJM197708042970506.
- Hachicha Z, Dumesnil JG, Pibarot P. Usefulness of the valvuloarterial impedance to predict adverse outcome in asymptomatic aortic stenosis. J Am Coll Cardiol. 2009;54(11):1003–11. doi:https://doi.org/10.1016/j.jacc.2009.04.079.
- Eleid MF, Nishimura RA, Sorajja P, Borlaug BA. Systemic hypertension in low-gradient severe aortic stenosis with preserved ejection fraction. Circulation. 2013;128(12):1349–53. doi:https://doi.org/10.1161/CIRCULATIONAHA.113.003071.
- Lindman BR, Arnold SV, Madrazo JA, Zajarias A, Johnson SN, Pérez JE, Mann DL. The adverse impact of diabetes mellitus on left ventricular remodeling and function in patients with severe aortic stenosis. Circ Heart Fail. 2011;4(3):286–92. doi:https://doi.org/10.1161/CIRCHEARTFAILURE.110.960039.
- Park SJ, Enriquez-Sarano M, Chang SA, Choi JO, Lee SC, Park SW, Kim DK, Jeon ES, Oh JK. Hemodynamic patterns for symptomatic presentations of severe aortic stenosis. JACC Cardiovasc Imaging. 2013;62(2):137–46. doi:https://doi.org/10.1016/j.jcmg.2012.10.013.
- Kang TS, Park S. Antihypertensive treatment in severe aortic stenosis. J Cardiovasc Imaging. 2018;26(2):45–53. doi:https://doi.org/10.4250/jcvi.2018.26.e9.
- Bang CN, Greve AM, Rossebø AB, Ray S, Egstrup K, Boman K, Nienaber C, Okin PM, Devereux RB, Wachtell K. Antihypertensive treatment with β-Blockade in patients with asymptomatic aortic stenosis and association with cardiovascular events. J Am Heart Assoc. 2017;6(12):e006709. doi:https://doi.org/10.1161/JAHA.117.006709.
- Mancusi C, de Simone G, Hitij JB, Sudano I, Mahfoud F, Parati G, Kahan T, Barbato E, Pierard LA, Garbi M, et al. Management of patients with combined arterial hypertension and aortic valve stenosis: a consensus document from the council on hypertension and council on valvular heart disease of the european society of cardiology, the european association of cardiovascular imaging (EACVI), the european association of percutaneous cardiovascular interventions (EAPCI). Eur Heart J Cardiovasc Pharmacother. 2020 Apr 30:pvaa040. Online ahead of print.
- Antonini-Canterin F, Huang G, Cervesato E, Faggiano P, Pavan D, Piazza R, Nicolosi GL. Symptomatic aortic stenosis: does systemic hypertension play an additional role?. Hypertension. 2003;41(6):1268–72. doi:https://doi.org/10.1161/01.HYP.0000070029.30058.59.
- Omran H, Fehske W, Rabahieh R, Hagendorff A, Pizzulli L, Zirbes M, Lüderitz B. Valvular aortic stenosis: risk of syncope. J Heart Valve Dis. 1996;5(1):31–34.
- Juraschek SP, Simpson LM, Davis BR, Beach JL, Ishak A, Mukamal KJ. Effects of antihypertensive class on Falls, syncope, and orthostatic hypotension in older adults: the ALLHAT trial hypertension. 2019;74(4):1033–40. doi:https://doi.org/10.1161/HYPERTENSIONAHA.119.13445.
- Wright JT Jr, Williamson JD, Whelton PK, SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373:2103–2016.
- Harada K, Saitoh T, Tanaka J, Shibayama K, Berdejo J, Shiota T. Valvuloarterial impedance, but not aortic stenosis severity, predicts syncope in patients with aortic stenosis. Circ Cardiovasc Imaging. 2013;6(6):1024–31. doi:https://doi.org/10.1161/CIRCIMAGING.113.000584.
- Dweck MR, Joshi S, Murigu T, Gulati A, Alpendurada F, Jabbour A, Maceira A, Roussin I, Northridge DB, Kilner PJ, et al. Left ventricular remodeling and hypertrophy in patients with aortic stenosis: insights from cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2012;14(1):50. doi:https://doi.org/10.1186/1532-429X-14-50.
- PM E, Gimeno Blanes JR, Mahon NG, Poloniecki JD, McKenna WJ. Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy. Lancet. 2001;357(9254):420–24. doi:https://doi.org/10.1016/S0140-6736(00)04005-8.
- Minners J, Rossebo A, Chambers JB, Gohlke-Baerwolf C, Neumann F-J, Wachtell K, Jander N. Sudden cardiac death in asymptomatic patients with aortic stenosis. Heart. 2020;106(21):1646–50. doi:https://doi.org/10.1136/heartjnl-2019-316493.